（来源：天津日报） 转自：天津日报 近日，在天津海河传媒中心主办的第十五届"榜样天津"企业社会责任展示活动中，天津康汇医院荣 获"新时代公益责任先锋"称号。这一荣誉既是对医院在民生服务与公益实践领域持续深耕的充分肯定， 也彰显了其作为民营医疗机构的示范作用。 在医疗领域，"担当"既是在危急重症前迎难而上的身影，更是日复一日在细微之处的坚守——它融入每 一次问候、每一场诊疗、每一处流程优化之中。作为一家三级综合医院，天津康汇医院以对患者无微不 至的关怀、对医术精益求精的追求，主动将社会责任扛在肩头，用温暖与专业诠释了新时代医者的使 命。 于细微之处见温暖 坚持"患者至上"的服务内核 走进天津康汇医院，患者首先感受到的是高效与便捷。10处经过精心规划、功能整合的"一站式服务中 心"，如同枢纽般分布在门诊、医技楼等人流密集区域，可确保患者走出诊室步行不超过五十米，便能 完成咨询、缴费、预约、检查到报告打印的全流程服务。医院力求通过精密的动线设计、资源整合与信 息互联，呈现给患者无须奔波、简单高效的便捷体验。 康汇医院追求"有温度的医疗"，这种追求深刻地浸润于那些看似无声却至关重要的细节之中。医院立志 成为民营医疗行 ...

据央视新闻，为应对老龄化严重及护工短缺，日本近年开始从印度培训并引进护理人员。 据悉，日本自2022年开始引进印度籍护工，当前在日的印度籍护工约有300人，尽管总数不多，但较前 一年增长73%。 日本知名护理服务提供商"日本财产保险护理公司"自2024年起在印度招募有护理工作经验的人员，对他 们进行大约9个月的日语和护理技能培训，然后协助他们办理赴日工作手续。今年，公司已经协助6名印 度护工赴日工作。 静冈县政府牵头组织本地护理服务提供商举行多次研讨会，希望增进他们对印度护工的了解，促进本地民 众对印度护工的接受程度。茨城县政府则组织人员赴印度考察，参观当地的日语学校及招聘机构。 日本政府估算，由于人口老龄化，到2040财年，日本的护理人员缺口将达到57万人。 三菱日联研究与咨询公司高级研究员加藤诚（音译）认为，从印度引进护工之举，仍有较大开发潜力。他 提醒，日本需要大力展示，在日从事护理行业具有稳定的职业路径。此外，日本还需改善外籍护工的整体 就业环境。 来源：央视新闻 责编：刘珺宇 校对： 廖胜超 百万用户都在看 "黑天鹅"突袭！刚刚，全线大跌！ A股，重要调整！ 杀疯了！半小时500亿元！刚刚，重磅利好 ...

为应对老龄化严重及护工短缺，日本近年开始从印度培训并引进护理人员。 据日本共同社14日报道，日本自2022年开始引进印度籍护工，当前在日的印度籍护工约有300人，尽管 总数不多，但较前一年增长73%。 三菱日联研究与咨询公司高级研究员加藤诚（音译）认为，从印度引进护工之举，仍有较大开发潜力。 他提醒，日本需要大力展示，在日从事护理行业具有稳定的职业路径。此外，日本还需改善外籍护工的 整体就业环境。 （文章来源：新华社） 日本知名护理服务提供商"日本财产保险护理公司"自2024年起在印度招募有护理工作经验的人员，对他 们进行大约9个月的日语和护理技能培训，然后协助他们办理赴日工作手续。今年，公司已经协助6名印 度护工赴日工作。 静冈县政府牵头组织本地护理服务提供商举行多次研讨会，希望增进他们对印度护工的了解，促进本地 民众对印度护工的接受程度。茨城县政府则组织人员赴印度考察，参观当地的日语学校及招聘机构。 日本政府估算，由于人口老龄化，到2040财年，日本的护理人员缺口将达到57万人。 ...

Core Viewpoint - Nanjing Xinbai's stock price has shown significant volatility, with a year-to-date increase of 28.96% and a recent decline of 2.00% on November 14, 2023, indicating potential market fluctuations and investor sentiment shifts [1][2]. Financial Performance - For the period from January to September 2025, Nanjing Xinbai reported a revenue of 4.773 billion yuan, a year-on-year decrease of 2.02%, and a net profit attributable to shareholders of 212 million yuan, down 4.14% compared to the previous year [3]. - The company has cumulatively distributed 1.117 billion yuan in dividends since its A-share listing, with 88.3827 million yuan distributed over the last three years [4]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased by 13.85% to 45,700, while the average circulating shares per person decreased by 12.17% to 25,485 shares [3]. - Nanjing Xinbai has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on July 24, 2023, where it recorded a net buy of -17.0404 million yuan [2]. Business Overview - Nanjing Xinbai, established on May 14, 1991, and listed on October 18, 1993, operates in various sectors including retail, healthcare, and elder care services. Its main revenue sources are health and elder care (36.97%), pharmaceutical manufacturing (23.74%), and medical services (15.26%) [2]. - The company is categorized under the comprehensive industry sector and is associated with concepts such as stem cells, gene sequencing, private hospitals, new retail, and undervalued stocks [2].

Core Viewpoint - Nanjing Xinbai is a leading enterprise in the commercial and health elderly care industry in China, with significant investment value due to its unique full industry chain resources [1] Group 1: Business Performance - In Q3 2025, Nanjing Xinbai achieved a revenue of 4.773 billion, ranking 6th in the industry, with the top company, Zhejiang Agricultural Shares, generating 33.084 billion [2] - The company's net profit for the same period was 285 million, placing it 4th in the industry, with the leading company, Dongyangguang, reporting 919 million [2] Group 2: Financial Ratios - As of Q3 2025, Nanjing Xinbai's debt-to-asset ratio was 26.47%, lower than the industry average of 53.00%, indicating strong solvency [3] - The gross profit margin for Q3 2025 was 41.64%, higher than the industry average of 18.56%, reflecting strong profitability [3] Group 3: Management and Shareholder Structure - The chairman, Cai Yong, has a strong educational background and extensive experience, while the president, Zhang Xuan, has maintained a stable salary of 1.06 million in 2024 [4] - As of September 30, 2025, the number of A-share shareholders increased by 13.85% to 45,700, with an average holding of 25,500 shares, a decrease of 12.17% [5]

Core Insights - The article discusses the profound and rapid aging of the population in China, highlighting the complexities and internal diversities within the elderly demographic, which is often overlooked by society and market research [4][10][18]. Group 1: Demographic Changes - The median age in developed economies has increased from 30 to 43 years over the past 50 years, with projections indicating it will reach 47 years by 2075. Emerging economies have seen a rise from 19 to 30 years [5]. - Global life expectancy has risen from 62 to 75 years in the last 50 years, with developed economies seeing an increase from 72 to 82 years [8]. - By the end of 2024, China's population aged 60 and above is expected to reach 310 million, accounting for 22% of the total population, marking the country’s entry into a deeply aging society [10]. Group 2: Aging Process and Definitions - Aging is a natural biological process experienced by nearly all animals, characterized by various physiological changes [12]. - The definition of "elderly" has evolved over time, with the World Health Organization defining elderly individuals as those aged 60 and above, while in developed countries, the age is often set at 65 [14]. Group 3: Internal Diversity of the Elderly Population - The elderly population in China is marked by significant internal diversity, with varying experiences and backgrounds leading to different consumption behaviors and needs [16][18]. - Historical events, such as the Great Chinese Famine and the Cultural Revolution, have created distinct generational experiences that influence the current elderly population's values and consumption patterns [20][21]. Group 4: Economic Disparities - There is a stark disparity in income among retirees in China, with pensions for civil servants being 28 times higher than those for rural residents [24]. - The elderly population's wealth is substantial, with the total wealth of individuals aged 60 and above in China reaching 78.4 trillion yuan, averaging 264,000 yuan per person [25]. Group 5: Consumption Patterns - The elderly consumer market is complex and multifaceted, with a significant portion of the population exhibiting low consumption levels despite the overall market potential [28][69]. - Many elderly individuals prioritize essential spending and exhibit high price sensitivity, often focusing on tangible benefits rather than abstract services [60][63]. Group 6: Digital Engagement - Approximately 52% of elderly individuals in China are internet users, indicating a significant digital divide where many remain disconnected from online resources [71]. - The COVID-19 pandemic has accelerated digital engagement among the elderly, with many being forced to learn to use smartphones for essential services [78]. Group 7: Market Opportunities - The elderly market presents a vast opportunity for businesses, but it requires a nuanced understanding of the diverse needs and preferences within this demographic [28][69]. - Companies must focus on tailored services and products that address the specific challenges faced by different segments of the elderly population, rather than adopting a one-size-fits-all approach [69].

Core Viewpoint - Nanjing Xinbai's 2025 semi-annual report indicates a slight decline in revenue but a modest increase in net profit, highlighting mixed financial performance in the first half of the year [1][2]. Financial Performance - The company's revenue for the first half of 2025 was 3.212 billion yuan, a year-on-year decrease of 1.20% [1]. - The net profit attributable to shareholders was 166 million yuan, reflecting a year-on-year increase of 0.76% [1]. - The net profit excluding non-recurring items was 135 million yuan, showing a year-on-year decline of 23.86% [1]. - Basic earnings per share stood at 0.12 yuan [1]. Profitability Metrics - The gross profit margin for the first half of 2025 was 42.87%, down 2.71 percentage points year-on-year [2]. - The net profit margin was 6.65%, a decrease of 0.58 percentage points compared to the same period last year [2]. - In Q2 2025, the gross profit margin was 42.65%, down 4.22 percentage points year-on-year and 0.46 percentage points quarter-on-quarter [2]. - The net profit margin for Q2 2025 was 3.23%, down 0.88 percentage points year-on-year and 7.00 percentage points quarter-on-quarter [2]. Expense Management - Total operating expenses for the first half of 2025 were 951 million yuan, a decrease of 96.4 million yuan compared to the previous year [2]. - The expense ratio was 29.59%, down 2.61 percentage points year-on-year [2]. - Sales expenses decreased by 6.08%, while management expenses decreased by 15.85% [2]. - Research and development expenses increased by 3.83%, and financial expenses rose significantly by 53.88% [2]. Shareholder Information - As of the end of the first half of 2025, the total number of shareholders was 40,200, a decrease of 1,797 shareholders or 4.28% from the previous quarter [2]. - The average market value per shareholder increased from 202,200 yuan to 225,300 yuan, reflecting an increase of 11.44% [2]. Company Overview - Nanjing Xinbai, established on May 14, 1991, and listed on October 18, 1993, operates in various sectors including retail, healthcare, and elderly care [3]. - The main revenue sources are health and elderly care (31.77%), pharmaceutical manufacturing (24.30%), and professional technical services (17.41%) [3]. - The company is categorized under the comprehensive industry and is associated with concepts such as stem cells, private hospitals, and the elderly care industry [3].

Core Insights - The company reported a revenue of 179 million yuan for the first half of 2025, with a significant year-on-year growth of 41.4% in nursing services, which has become a new growth engine for the business [2] - The adjusted net loss for the period was 38.4 million yuan, representing a year-on-year reduction of 25.1% [2] Business Model and Performance - The company operates on a "city cloud hospital platform" as its core business model, with over 36,000 medical institutions connected to the platform as of June 30, 2025, including 3,303 hospitals, which is a year-on-year increase of 24.5% [2] - The number of registered doctors on the platform reached 147,000, marking an 8.0% year-on-year growth, while the number of registered nurses with over five years of clinical experience reached 145,000, showing a substantial year-on-year increase of 34.1% [2] Revenue Breakdown - In the first half of 2025, the nursing services segment generated a revenue of 34.62 million yuan, reflecting a significant year-on-year increase of 41.4% [2] - The medical services segment reported a revenue of 69.83 million yuan, as the company optimized its structure by focusing on specialized operations of internet hospitals [2] - The health management services segment achieved a revenue of 74.15 million yuan, with a year-on-year growth of 10.5% [2]

Core Insights - The company reported a revenue of 179 million yuan for the first half of 2025, with a significant year-on-year growth of 41.4% in nursing services, marking it as a new growth engine for the business [1] - The adjusted net loss for the period was 38.4 million yuan, which represents a year-on-year reduction of 25.1% [1] Business Model and Performance - The company operates on a "city cloud hospital platform" as its core business model, with over 36,000 medical institutions connected to the platform as of June 30, 2025, including 3,303 hospitals, reflecting a year-on-year growth of 24.5% [1] - The number of registered doctors on the platform reached 147,000, an increase of 8.0% year-on-year, while the number of registered nurses with over five years of clinical experience grew by 34.1% to 145,000 [1] Segment Performance - In the first half of 2025, the nursing services segment generated a revenue of 34.62 million yuan, showing a substantial year-on-year increase of 41.4% [1] - The medical services segment reported a revenue of 69.83 million yuan, as the company optimized its structure by focusing on specialized operations of internet hospitals [1] - The health management services segment achieved a revenue of 74.15 million yuan, reflecting a year-on-year growth of 10.5% [1]

Core Insights - The company reported a revenue of 179 million yuan for the mid-year period of 2025, indicating a significant growth in its operations [1] - The nursing services segment experienced a year-on-year revenue increase of 41.4%, emerging as a new growth driver for the company [1] - The adjusted net loss for the period was 38.4 million yuan, which represents a 25.1% reduction compared to the previous year [1]